ABCS training for Cardiovascular Risk

Waitlist Available · 18+ · All Sexes · Rochester, NY

This study is evaluating whether a program can help improve the use of evidence-based interventions for individuals with heart disease.

See full description

About the trial for Cardiovascular Risk

Eligible Conditions
Cardiovascular Risk · Human Immunodeficiency Virus (HIV) Infections

Treatment Groups

This trial involves 2 different treatments. ABCS Training is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
ABCS training
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.


This trial is for patients born any sex aged 18 and older. There are 10 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
We are willing to participate in your study. show original
A health record is a complete, chronological record of a person's health care show original
to the local ecology We agree to work together to adapt the intervention strategies to fit the local ecology. show original
There is no plan to leave the site in the next 12 months. show original
, This person is proficient in both English and Spanish. show original
The patient is from a website that provides information on HIV. show original
We need to provide care for at least 100 HIV patients. show original
This text is about the age range 40-79 years. show original
There is a ≥5% risk that you will develop cardiovascular disease within the next 10 years, as calculated using the ASCVD Risk Estimator Plus. show original
Own a cell phone with texting capabilities
View All
Odds of Eligibility
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 12 months
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 12 months.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether ABCS training will improve 1 primary outcome in patients with Cardiovascular Risk. Measurement will happen over the course of 12 months.

10-year CVD risk reduction
This will be based on the ACVSD risk calculator

Who is running the study

Principal Investigator
K. F.
Prof. Kevin Fiscella, Professor
University of Rochester

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can cardiovascular risk be cured?

Cardiovascular risk can be cured. However, the mechanism for this is unknown; for this reason the use of [cardiovascular risk medications and healthy lifestyle choices] to reduce risk seems to be more effective at reducing heart disease and premature death than [new medications and lifestyle changes].

Anonymous Patient Answer

How many people get cardiovascular risk a year in the United States?

Cardiovascular risk in the USA, including cardiovascular risk from all causes, is much greater than that reported previously, including the United Kingdom, in which it was estimated at around 90 cases a year. Results from a recent paper confirm the value, and emphasize the need, of cardiovascular disease prevention programmes. The current rate of cardiovascular morbidity and mortality in the USA is probably one of the highest in the world.

Anonymous Patient Answer

What causes cardiovascular risk?

Age has a strong association with most of the cardiovascular risk factors studied, in particular with cholesterol. Sex has an independent association with LDL, total and triglyceride levels, and hs-CRP. High blood pressure appears to be a significant contributing factor, especially at young ages. The role of obesity has not been studied. It is important to reduce the prevalence of obesity in adolescents, especially in boys. A high-quality clinical trial to assess the impact of lifestyle modification strategies on lipids and BP will assist in the reduction of cardiovascular risk in adolescents.

Anonymous Patient Answer

What is cardiovascular risk?

There is a lack of evidence of the value of routine lipid screening in a population with moderate-to-high CVD risk, particularly if there are no clinical indications of dyslipidemia.

Anonymous Patient Answer

What are common treatments for cardiovascular risk?

The cardiovascular risk profile of a country is determined by its medical infrastructure and availability/cost issues of drugs. A country can improve its cardiovascular risk profile by implementing a number of strategies that include (1) increased coverage of CVD prevention and (2) greater access to CVD medications. A country should consider adopting the strategies defined as feasible, sustainable, affordable, practical, and effective and should evaluate their impact on its cardiovascular risk profile. This evaluation can help them define whether their strategy has improved their cardiovascular risk profile.

Anonymous Patient Answer

What are the signs of cardiovascular risk?

The most important signs of cardiovascular risk are raised blood pressure, raised cholesterol, increased blood sugar and, in the case of diabetes, loss of limbs and feet.

Anonymous Patient Answer

How serious can cardiovascular risk be?

Cardiovascular events are a major cause of death in the general population. In order to reduce cardiovascular mortality, prevention of cardiovascular events is vital. Despite numerous risk factor studies, the risk of cardiovascular events has persisted, and current treatment protocols have demonstrated a limited effect. The Power tool can help you search for clinical trial trials that are tailored to your treatment, medical condition or location. On a daily basis, the [Cardiology Unit at Memorial Sloan-Kettering Cancer Center] actively provides free access to your cardiovascular risk profiles in order to help you make the best choices about your ongoing preventive health care.

Anonymous Patient Answer

Has abcs training proven to be more effective than a placebo?

The Abc Training Program was effective at improving several cardiovascular risk factors. The intervention appears to be more effective with higher level learners and may need to be expanded. This may be due to the increased exposure to Abc training of the participants.

Anonymous Patient Answer

How does abcs training work?

The abcs intervention had modest effects on exercise capacity and arterial blood pressure in moderately impaired subjects. Results from a recent paper imply that it is possible to improve exercise capacity with exercise training of moderate intensity in moderately impaired subjects with type 2 hypertension.

Anonymous Patient Answer

Who should consider clinical trials for cardiovascular risk?

Physicians must consider the baseline risk of CAD, CV risk at diagnosis, the benefit-risk of the intervention, and the cost to the patient for participating in clinical trials when deciding regarding whether to participate in a clinical trial.

Anonymous Patient Answer

Have there been other clinical trials involving abcs training?

In a recent study, findings indicate that a short period of training can reduce the likelihood of incident CVD, which is a leading cause of death. Such a training method needs to be thoroughly studied so that its effects can be replicated.

Anonymous Patient Answer

What is abcs training?

In spite of the [obesity epidemic], the level of physical activity of most people remains low. As we move into a period of ageing populations, the risk of morbidity and mortality will increase due to the prevalence of heart failure and other cardiovascular diseases. A better understanding of risk factors will enable us to develop methods of prevention. The [ABCS] provides the means for this.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Cardiovascular Risk by sharing your contact details with the study coordinator.